Post-IPO Equity Pharmaceutical Companies

Nutriband is an innovative and progressive health and lifestyle company.

Aurora Cannabis is a medical marijuana producer that provides its patients quality products, customer service, and affordable pricing.

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Sproutly is the supplier of unique ingredients and customized formulations to the cannabis beverage and edibles market.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Allied produces premium craft cannabinoid health products that support PTSI patients.

Devonian is a late stage botanical pharmaceutical corporation

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

One of the most innovative consumer healthcare and beauty companies in North America.

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Grid AI delivers innovative energy management solutions for homes, businesses, and industrial campuses.

Revive Therapeutics is focused on the research, development and commercialization ofnovel therapies and technologies company.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.